METASTATIC THYROID GLAND CARCINOMA

This study is testing whether a combination of targeted drugs, with or without an immunotherapy drug, can help control advanced thyroid cancer that has spread and no longer responds to standard radioactive iodine treatment. It is for patients whose cancer has a specific genetic c…

This study is testing whether two drugs, lenvatinib and pembrolizumab, work better together for people with advanced anaplastic thyroid cancer that cannot be removed by surgery or has spread. Lenvatinib aims to block tumor growth, while pembrolizumab helps the body's immune syste…

This early-stage study is testing the safety and best dose of a two-drug combination (dabrafenib and lapatinib) for adults with advanced thyroid cancer that has a specific genetic change (BRAF mutation) and has stopped responding to standard treatments. The main goal is to see ho…

This study is testing whether combining a drug that helps the immune system fight cancer (atezolizumab) with different chemotherapy drugs can help people with aggressive forms of thyroid cancer that have spread or cannot be removed by surgery. The goal is to see if this combinati…

This study is testing if adding an oral drug called trametinib can make radioactive iodine treatment work again for people with advanced thyroid cancer that has spread or come back and no longer responds to iodine. The goal is to see if trametinib helps the cancer absorb more iod…